2nd Circuit Dupixent news shows skin cancer cases across New York, Connecticut, and Vermont. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims.
To learn more, please see our information on claiming a 2nd Circuit Dupixent settlement.
New York Dupixent News
New York Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- NY Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a New York Dupixent lawsuit.
Connecticut Dupixent News
Connecticut Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- CT Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a Connecticut Dupixent lawsuit.
Vermont Dupixent News
Vermont Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- VT Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a Vermont Dupixent lawsuit.
2nd Circuit Dupixent News Supports MDL Settlement for Skin Cancer
2nd Circuit Dupixent news of T-cell lymphoma has raised concerns for eczema and asthma patients in New York, Connecticut, and Vermont. As such, public support is growing for the court’s certification of a Dupixent Multi-District Litigation (MDL) to administer claims.
Lymphoma Attorneys Act on 2nd Circuit Dupixent News of Skin Cancer
Reporting skin cancer is an important first step to justice. If your family has been impacted by Dupixent, contact us about filing a 2nd Circuit settlement claim.
For background information on T-cell lymphoma, please see our Dupixent lawyers homepage.